Pharma

Pharma

An Estimated 60% of All Asthma Cases Go Undiagnosed in the UK

Currently in the UK, there are over nine million lifetime diagnosed prevalent cases of asthma and approximately 13 million undiagnosed asthma patients, says GlobalData, a leading data and analytics company. Bahram Hassanpourfard, Epidemiologist Analyst at GlobalData, comments: “The testing limitations of asthma in primary care services likely result in a high number of undiagnosed patients. NHS […]

Pharma

Janssen’s PP6M set to be promising treatment to increase compliance rates in schizophrenia

Following the news that Janssen has submitted a Marketing Authorisation Extension to the European Medicines Agency (EMA) for its product paliperidone palmitate 6-Monthly (PP6M) for the treatment of schizophrenia in adults; Alessio Brunello, Managing Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “Antipsychotic medication are the most prescribed in schizophrenia, […]

Pharma

Rheumatoid arthritis burden to increase by 10.6% over the next decade in the 8MM

The diagnosed prevalent cases of rheumatoid arthritis (RA) in the eight major markets (*8MM) is expected to increase from 4.6 million cases in 2019 to 5.1 million in 2029, at an annual growth rate (AGR) of 1.06%, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Rheumatoid Arthritis – Epidemiology Forecast […]

Pharma

Global clinical trial resumptions still growing but increasing COVID-19 cases and lockdowns in UK and US slowing growth

Lockdowns in the UK and some US states may be contributing to the slight slowing in the trajectory of ‘resumed’ trials, says GlobalData, a leading data and analytics company. The number of resumed trials increased from 797 on 12 October to 841 on 16 November. However this value only increased by 44 trials, the smallest […]

Pharma

COVID-19 vaccines have promising results and have created optimism in mRNA research space

Two recent Phase III mRNA COVID-19 vaccine trials resulted in 95% efficacy and generally well-tolerated safety profiles for vaccines BNT162b2 and mRNA-1273, developed by Pfizer/BioNTech and Moderna, respectively. As no mRNA vaccines had been approved for human use, these clinical trials have created optimism in this research space, says GlobalData, a leading data and analytics […]

Pharma

Canada sets out COVID-19 plans to vaccinate a majority by September 2021

Following Prime Minister Justin Trudeau’s announcement of Canada’s vaccination schedules; James Spencer, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “With the recent announcement of several potential COVID-19 vaccines one after another, countries around the world have been scrambling to put together their vaccine plans. “Trudeau stated that he expects […]

Pharma

Regenerative medicine market to reach $16.4bn in 2026 driven by gene and cell therapies

The field of regenerative medicine (RM) is rapidly expanding as there are currently 53 marketed RM products and 175 RM pipeline agents in development in the eight major markets (8MM*), according to GlobalData, a leading data and analytics company. The company’s report, ‘Regenerative Medicine in Pharma – Thematic Research’, states that gene therapy is the […]

Pharma

Biogen collaboration with Sage Therapeutics shows promise for novel MDD treatment

Following the news that Biogen have entered into a licensing agreement with Sage Therapeutics to jointly develop and commercialize zuranolone (SAGE-217) and SAGE-324; Philippa Salter, Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “This licensing deal will allow Biogen to expand its already strong neurology portfolio, while Sage Therapeutics will […]

Pharma

BioNTech/Pfizer COVID-19 fast vaccine approval translates into less logistical challenges for the UK

Following recent news that the UK will become one of the first countries in the Western world to authorize a COVID-19 vaccine; Urte Jakimaviciute, Senior Director of Market Research at GlobalData, a leading data and analytics company, shares her views: “Despite being a part of European Medicines Agency (EMA), the UK became the first EU […]

Pharma

Novartis’ registration of head-to-head psoriatic arthritis clinical trial begins the battle for second place,

Novartis recently registered a Phase III psoriatic arthritis (PsA) clinical trial of its IL-17 inhibitor Cosentyx (secukinumab) compared against Johnson & Johnson’s Stelara (ustekinumab). The registration of this trial demonstrates Novartis’ continued efforts to solidify its position in an increasingly crowded market, according to GlobalData, a leading data and analytics company. Tiffany Chan, Immunology Analyst […]

Pharma

China to see over 14,400 diagnosed incident cases of acute lymphocytic leukemia by 2029 – the highest in the 8MM

The number of diagnosed incident cases of acute lymphocytic leukemia (ALL) in the eight major markets (8MM*) is projected to increase from 23,729 in 2019 to 26,482 in 2029, with an annual growth rate (AGR) of 1.16%, according to GlobalData, a leading data and analytics company. Urban China will have the highest number of cases […]

Pharma

Influenza cases down from last year in the US but COVID-19 increases the risks

In the Northern Hemisphere, flu season is beginning in conjunction with the COVID-19 pandemic, however, influenza-like activity remains low in the US, with 40% fewer cases of influenza-like illness (ILI) than in the same time last year. Nonetheless, with healthcare resources stretched thin as a result of the pandemic, the risk of a bad flu season […]

Pharma

Bladder cancer therapeutics market projected to exceed $5.5bn by 2028

The bladder cancer therapeutics market was valued at $670m in 2018 across the seven major markets (7MM*) and is expected to grow exponentially at a compound annual growth rate (CAGR) of 23.6% – accruing slightly less than $5.6bn in 2028, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Bladder Cancer Opportunity […]

Pharma

Lifetime diagnosed prevalent cases of asthma in 7MM set to surpass 89 million in 2029

The burden of diagnosed asthma is expected to increase at a compound annual growth rate (CAGR) of 0.31% from around 86.7 million cases in 2019 to 89.4 million cases in 2029 in the seven major markets (7MM*), according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Asthma: Epidemiology Forecast to 2029’, reveals […]

Pharma

Following landmark approval, Pfizer and BioNTech can use UK as test bed for cold chain distribution

Following the news that Pfizer/BioNTech’s COVID-19 vaccine BNT162b2 received emergency use approval from UK health authorities; Philipp Rosenbaum, PhD, Senior Infectious Diseases Analyst at GlobalData, a leading data and analytics company, offers his view: “The UK represents an ideal test bed for the delivery of Pfizer’s vaccine. The country’s small size, dense population and strong […]

Pharma

China pulls ahead in immuno-oncology with highest PD-1/PD-L1 combination clinical trials growth, reveals GlobalData

China recorded the highest year-on-year increase in the number of clinical trials initiated investigating PD-1/PD-L1 targeted combination immuno-oncology therapies across the eight major markets (8MM*) in 2020, according to GlobalData, a leading data and analytics company. In 2020, the US emerged as the leading market in industry-sponsored initiated clinical trials for PD-1/PD-L1 targeted combination therapies […]

Pharma

US cannot wait on vaccines to curb pandemic as COVID-19 cases trend towards 100 million by July 2021

If the current trend in US COVID-19 cases continue, over 30% of the US population will have contracted the virus by July 2021, according to GlobalData forecasts Given that vaccines will need many more months to be approved, manufactured, and distributed to the general population, the US cannot rely only on vaccines to curb the […]

Pharma

Acute lymphocytic leukemia market is forecast to reach $2.26bn by 2029

The acute lymphocytic leukemia (ALL) market has enjoyed explosive growth since 2015 and is expected to increase further, albeit at a slower pace, from $1.46bn in 2019 to $2.26bn in 2029 across the eight major markets (8MM*) at a moderate compound annual growth rate (CAGR) of 4.4%, according to GlobalData, a leading data and analytics […]

Pharma

Pancreatic ductal adenocarcinoma diagnosed incident cases set to reach 225,000 in 2029

The burden of diagnosed pancreatic ductal adenocarcinoma (PDAC) is expected to increase at an annual growth rate (AGR) of 2.60% from around 180,000 cases in 2019 to 225,000 cases in 2029 in the eight major markets (8MM*), according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Pancreatic Cancer – Epidemiology Forecast to […]

Pharma

Phase III data for Omecamtiv Mecarbil and Finerenone demonstrates reduced risk of cardiovascular events at AHA conference

A record number of late-breaking trials were submitted to the Annual Scientific Sessions of the American Heart Association (AHA) this year and unsurprisingly, a key theme of this year’s conference was the COVID-19 pandemic, says GlobalData, a leading data and analytics company. Fiona Chisholm, Managing Analyst at GlobalData, comments: “One notable study, which analyzed records […]

Prev 1 … 73 74 75 76 77 … 108 Next

An Estimated 60% of All Asthma Cases Go Undiagnosed in the UK

Janssen’s PP6M set to be promising treatment to increase compliance rates in schizophrenia

Rheumatoid arthritis burden to increase by 10.6% over the next decade in the 8MM

Global clinical trial resumptions still growing but increasing COVID-19 cases and lockdowns in UK and US slowing growth

COVID-19 vaccines have promising results and have created optimism in mRNA research space

Canada sets out COVID-19 plans to vaccinate a majority by September 2021

Regenerative medicine market to reach $16.4bn in 2026 driven by gene and cell therapies

Biogen collaboration with Sage Therapeutics shows promise for novel MDD treatment

BioNTech/Pfizer COVID-19 fast vaccine approval translates into less logistical challenges for the UK

Novartis’ registration of head-to-head psoriatic arthritis clinical trial begins the battle for second place,

China to see over 14,400 diagnosed incident cases of acute lymphocytic leukemia by 2029 – the highest in the 8MM

Influenza cases down from last year in the US but COVID-19 increases the risks

Bladder cancer therapeutics market projected to exceed $5.5bn by 2028

Lifetime diagnosed prevalent cases of asthma in 7MM set to surpass 89 million in 2029

Following landmark approval, Pfizer and BioNTech can use UK as test bed for cold chain distribution

China pulls ahead in immuno-oncology with highest PD-1/PD-L1 combination clinical trials growth, reveals GlobalData

US cannot wait on vaccines to curb pandemic as COVID-19 cases trend towards 100 million by July 2021

Acute lymphocytic leukemia market is forecast to reach $2.26bn by 2029

Pancreatic ductal adenocarcinoma diagnosed incident cases set to reach 225,000 in 2029

Phase III data for Omecamtiv Mecarbil and Finerenone demonstrates reduced risk of cardiovascular events at AHA conference

Browse

Company information